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ABSTRACT We have previously isolated from a 1246
adipocyte cDNA library a cDNA done called 154, correspond-
ing to a mRNA that increases abun tly at a very early time
during the differentiation of 1246 adipocytes and in adipocyte
precursors in primary culture. We show here that the mRNA
encoded by this cDNA is expressed abundantly and preferen-
tially in mouse fat pads. A full-length cDNA for clone 154 was
isolated by the RACE (rapid amplification of cDNA ends)
protocol. Sequence analysis of this cDNA indicates that it
encodes a protein of the 425 amino acids [tentatively named
adipose differentiation-related protein (ADRP)] that does not
have any simlarity with sequences contained in the GenBank
DNA and Protein Identiflcation Resource protein data bases.
Immunoblot of 1246 cell extracts with an antibody raised
against the expressed ADRP shows that the 1246 cells contain
a 50-kDa protein, the production ofwhich increases as the cells
differentiate. Localization ofADRP in 1246 cells indicates that
ADRP is absent from nuclear and cytosolic fractions and is
found as a membrane-associated protein. These results dem-
onstrate that adipocyte differentiation is accompanied by early
expression of a mRNA encoding a membrane-associated adi-
pose differentiation related protein that is adipose tissue spe-
cific in vivo.
Elucidation of molecular events occurring during adipose
differentiation has been greatly facilitated with the isolation
and characterization of genes that are activated during the
process of differentiation (1). Fat cells express proteins and
mRNAs that are distinct from other cell types and that
determine their ability to carry out their specialized functions
(2, 3). cDNA libraries have been established by using mRNA
isolated from several adipogenic cell lines and screened either
by differential hybridization (4-7) or by subtraction methods
(8). The application ofthese techniques has led to isolation of
cDNAs encoding proteins induced during adipose differen-
tiation and involved in lipid metabolism in the adipocytes.
Moreover, cDNAs coding for newly discovered adipose
tissue-specific proteins were obtained (4-8). The character-
ization of these genes and elucidation of the function of the
proteins they encode will help to better understand the
specialized properties of the adipocytes. In our laboratory,
we have been studying adipose differentiation by using a C3H
mouse teratoma-derived adipogenic cell line called 1246 (9).
It was shown that 1246 cells could proliferate and differen-
tiate in defined medium and that insulin was required for both
processes (10). Recently, we have constructed a cDNA
library of fully differentiated 1246 cells cultivated in defined
medium. Among the cDNAs isolated, clone 154 was partic-
ularly interesting and was further characterized. Clone 154
contains a 0.8-kilobase (kb) insert and hybridizes to a 1.7-kb
mRNA, which is induced at a very early stage during the
onset of adipose differentiation in 1246 cells and in adipocyte
precursors in primary culture (11). Our results show that
clone 154 mRNA is induced 100-fold by day 1 of differenti-
ation. This induction of clone 154 mRNA occurs 1 day earlier
than lipoprotein lipase, which is considered to be an early
marker of adipose differentiation. Expression of clone 154
mRNA is enhanced by the addition of stimulators of differ-
entiation such as dexamethasone and isobutylmethylxan-
thine and is repressed by factors that are potent inhibitors of
1246 cell differentiation, such as transforming growth factor
,(, tumor necrosis factor, and epidermal growth factor (11).
Sequencing of the clone 154 0.8-kb insert revealed an open
reading frame whose nucleotide sequence and deduced
amino acid sequence had no similarity with sequences in the
GenBank and Protein Identification Resource protein data
bases. Considering that clone 154 is the earliest marker of
adipocyte differentiation reported to date and appears to
encode a newly discovered polypeptide, we have pursued the
characterization of the 154 gene product referred to as
adipose differentiation-related protein (ADRP). We report
here the molecular cloning of the entire coding sequence of
ADRP by using the rapid amplification of cDNA ends
(RACE) technique (12) and the characterization ofADRP in
1246 cells and in adipose tissue.t
MATERIALS AND METHODS
Animals. Three-month-old C57BL/6J mice from The Jack-
son Laboratory were used for total RNA isolation from
various tissues. Male Chinchilla rabbits (4-5 lb) were pur-
chased from Cornell University (Ithaca, NY) and used for
raising antisera.
Northern Blot Analysis. Differentiation of 1246 cells in
defined medium was carried out as described (11). Total
cellular RNA from undifferentiated and differentiated cells
was isolated by the method of Chirgwin et al. (13). Poly(A)+
RNA was twice purified by chromatography on oligo(dT)-
cellulose (Collaborative Research) according to Aviv and
Leder (14). The method for total RNA isolation from mouse
tissues was described by Chomczynski and Sacchi (15).
Northern blot analysis of clone 154 mRNA expression was
performed as described (11).
DNA Amplification by PCR. The RACE protocol, as de-
scribed by Frohman et aL (12), was used to obtain cDNAs
containing the 5' and 3' coding regions of clone 154. First-
strand cDNA was synthesized from 1-5 ,jg of poly(A)+ RNA
from fully differentiated 1246 cells by using a red module kit
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(Invitrogen, San Diego). Forty cycles of amplification were
carried out for each PCR. Each cycle consisted of a dena-
turation step (940C; 1 min), an annealing step (50'C-550C; 2
min), and an extension step (720C; 3 min). The final ampli-
fication cycle was followed by a 10-min extension reaction at
72TC. The oligonucleotide 5'-AACCAAGGGCCTCAT-
TATGGTC-3' (underlined in Fig. 2) was used as a 3' RACE
primer. The two primers used for 5' RACE were 5'-ACTC-
GATGTGCTCAACACAGTG-3' (5-RT) and 5'-CGTCG-
TAGCCGATGCTTCTCTT-3' (5-Amp) (see Fig. 2). The
primer 5-RT was used to direct first-strand cDNA synthesis,
whereas primer 5-Amp was used as one of the amplification
primers as described by Frohman et al. (12). The cDNA
fragment containing the entire coding sequence for ADRP
was amplified by PCR using two primers each having a Xma
I (Sma I) site. The two primers are HP-1 (5'-CTGACCCGG-
GATGGCAGCAGCAGTAGTGGATC-3') and HP-2 (5'-
CTGACCCGGGTTTACTGAGCTTTGACCTCAGA-3').
The 3' and 5' RACE products of clone 154 were purified by
electrophoresis in an agarose gel and then electroeluted. The
purified cDNAs were blunt-end ligated into the Sma I site of
the pBluescript SK vector (Stratagene) using T4 DNA ligase
(GIBCO/BRL). The PCR-amplified entire coding region for
ADRP was digested with the restriction enzyme Xma I (New
England Biolabs) and purified by gel electroelution. The
purified cDNA was then cloned into the Xma I site in
Bluescript SK vector. The recombinant plasmids were puri-
fied and the inserts were sequenced by the dideoxynucleotide
chain-termination method (16).
Production of Polyclonal Antibodies Against ADRP.
pGEX-2T (17) (Pharmacia) was used as a vector to express
ADRP in the form of a fusion protein with the 27-kDa
glutathione S-transferase (GST; RX: glutathione R-transfer-
ase, EC 2.5.1.18) in bacteria as described by Smith and
Johnson (17). pGEX-2T vector was first digested with
BamHI, then treated with Klenow fragment, and religated.
The vector DNA was then digested with Xma I and ligated
with the Xma I-treated cDNA fragment containing the entire
coding region for ADRP as described above, therefore mak-
ing ADRP in-frame with GST. The orientation of the cDNA
encoding ADRP in the plasmid was determined by Pst I
mapping. The GST-ADRP fusion protein was purified by
glutathione Sepharose-4B (Pharmacia) affinity chromatogra-
phy according to the manufacturer's procedure. Affinity-
purified GST-ADRP fusion protein (150 ug of protein per
injection) was used as an antigen to raise antisera in chinchilla
rabbits using the Ribi adjuvant system (Ribi Immunochem).
The GST-ADRP fusion protein was denatured by either 0.5%
SDS or 8 M urea to expose the entire primary structure of this
protein before the injection. ADRP antiserum was immu-
noaffinity-purified by GST Sepharose chromatography be-
fore being used.
Preparation of Cell Lysate and Subcellular Fractions from
1246 Cells for Immunoblot. Differentiation of 1246 cells in
defined medium was carried out as described (11). At each
time point, cells were washed with phosphate-buffered saline
(PBS) and lysed in 62.5 mM Tris-HCl (pH 6.8) containing 10%o
glycerol and 2% SDS. The final volume of this cell lysate was
measured and the protein concentration was determined by
using a micro-BCA protein assay reagent kit (Pierce). At
equivalent time points, the cell number from duplicate plates
of 1246 cells was determined in order to use cell lysates
containing the same number of cells for Western blot anal-
ysis. For preparation of subcellular fractions, differentiated
1246 cells were collected on day 8. Briefly, 1246 cells were
washed with PBS twice, gently scraped off the culture dishes,
and pelleted by low-speed centrifugation. Cells were resus-
pended in TSM buffer (10 mM Tris-HCl, pH 7.4/10 mM
NaCl/3 mM MgCl2) containing EDTA (5 mM), aprotinin (10
pug/ml), leupeptin (10 pg/ml), pepstatin A (10 Mg/ml), and
phenylmethylsulfonyl fluoride (0.2 mM) as protease inhibi-
tors and homogenized with 10 strokes at =800 rpm. The
homogenate was centrifuged at 600 x g for 5 min. The
particulate and cytosol fractions were separated by ultracen-
trifugation of the supernatant at 100,000 x g for 60 min. The
nuclear fraction was obtained by resuspending the 600 x g
pellet in sucrose solution (0.25 M sucrose/10 mM Tris-HCl,
pH 7.4/2 mM MgCl2) and recentrifuged at 600 x g. Equal
amounts of protein from each fraction were applied for
immunoblotting.
For analysis of 154 protein expression in cell and tissue
samples by immunoblot, electrophoresis on a SDS/10%
polyacrylamide gel was performed (18). Proteins were elec-
trophoretically transferred to 0.2-,um poly(vinylidene difluo-
ride) membranes (Millipore). The membranes were blocked
with TBS (20 mM Tris/500 mM NaCl, pH 7.5) containing 5%
nonfat milk for 1 hr at room temperature and rinsed twice
with TBS. The membranes were then incubated with a 1:200
dilution of ADRP antiserum for 1-2 hr in TBS/1% bovine
serum albumin at room temperature followed by several
washes with TTBS (TBS/0.05% Tween 20) and incubated
with alkaline phosphatase-conjugated goat anti-rabbit IgG for
1 hr. Bound antibodies were visualized by color development
with substrates NBT (nitroblue tetrazolium) and BCIP (5-
bromo-4-chloro-3-indolyl phosphate) (Bio-Rad).
Immunofluorescence Microscopy. 1246 cells were cultured
in chamber slides (Nunc) at a density of 0.2 x 104 cells per
cm2 and differentiation of the 1246 cells was carried out. At
day 8, the 1246 cells were washed with PBS, fixed, and
permeabilized by cold methanol as described by Osborn and
Weber (19); then they were incubated with either nonimmune
serum or anti-ADRP antiserum at room temperature for 1 hr,
washed with PBS, and incubated with fluorescein isothiocy-
anate-conjugated goat anti-rabbit IgG for 1 hr. The bound
antibodies were visualized by immunofluorescence micros-
copy.
Sequence Analysis. Software and data bases for sequence
analysis were provided by IntelliGenetics. Sequence similar-
ity searches were performed with the GenBank (release 69)
and Swiss-Prot (release 19) data bases.
RESULTS
Tissue-Specific Expression of Clone 154 mRNA in Vivo. We
have previously shown that clone 154 mRNA is expressed
abundantly during differentiation of 1246 cells as well as in
adipocyte precursors in primary culture (11). Here we deter-
mined the tissue distribution of 154 mRNA in vivo. As shown
in Fig. 1, clone 154 mRNA was predominantly expressed in
mouse inguinal and epididymal fat pads and was virtually
undetected in liver, kidney, heart, and brain. The size of 154
Clone 154- 0w
FIG. 1. Tissue distribution of clone 154 mRNA. Total RNA from
mouse kidney, liver, heart, brain, and inguinal fat pad (FP) was
isolated and 15 'g ofRNA from each tissue was loaded on each lane
of a denaturing agarose gel for Northern blotting analysis.
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mRNA in adipose tissue was similar to that found in 1246 cells
and differentiated adipocyte precursors in primary culture.
Molecular Cloning of the Entire Coding Sequence of Clone
154 by Using the RACE Protocol. The 823-base-pair (bp) clone
154 isolated from the 1246 differentiated cDNA library (11)
was sequenced by the dideoxynucleotide chain-termination
method (16). Computer-assisted analysis of the clone 154
cDNA sequence (823 bp) indicated that clone 154 cDNA
contained an open reading frame and had no similarity to
DNA sequences in the GenBank data base. Moreover, the
putative protein encoded by the major open reading frame of
clone 154 cDNA also showed no similarity to protein se-
quences in the protein data base. This suggested that the
clone 154 mRNA encoded a newly discovered protein. Thus,
it was of interest to isolate and determine the complete
nucleotide-sequence of the full-length transcript correspond-
ing to clone 154 and the amino acid sequence of its encoded
protein. To obtain the sequence information of the 5' and 3'
regions flanking the original 823-bp cDNA, we used the
RACE technique (12). The cDNA strand that contained the
TAGTGGTGAT CTGGACCGTG CGGACTTGCT CGTCCCTCAG
TTTCTCCAGG AGGAAAA1SCAGCAGCA GTAGTGGATC
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major open reading frame was assumed to be the (+)-strand.
The 3' RACE reaction was performed by using as primer an
oligonucleotide complementary to the (-)-stand as shown
underlined in Fig. 2. The 3' RACE reaction yielded a 0.3-kb
fragment, which hybridized strongly to 32P-labeled clone 154
cDNA (data not shown). This 0.3-kb fragment was cloned
into the Sma I site in pBluescript SK vector by blunt-end
ligation and sequenced. Three clones from different PCRs
containing the 0.3-kb 3' RACE fragment were sequenced in
order to eliminate possible PCR errors. Our results showed
that this 0.3-kb fragment covered most of the 3' sequence of
the original clone 154 with several additional nucleotides
followed by a poly(A) tail (Fig. 2). In addition, the 3' RACE
results confirmed that our assumed direction of clone 154 is
correct.
The 5' RACE reaction was carried out using clone 154-
specific oligonucleotides as primers. The sequences of both
primers, referred to as 5-RT and 5-Amp in Fig. 2, are
complementary to the (+)-strand. The primer 5-RT was used
to direct first-strand cDNA synthesis, while 5-Amp was used
CTCTCCTGTT AGGCGTCTCT
CGCAACAGAG CGTGGTGATG
14 M A A A V V D P Q Q S V V M
AGAGTGGCCA ACCTGCCCTT GGTGAGCTCT ACCTACGACC TTGTGTCCTC CGCTTATGTC
34 R V A N L P L V S S T Y D L V S S A Y V
AGTACAAAGG ATCAGTACCC GTATTTGAGA TCCGTGTGTG AGATGGCCGA GAAGGGCGTG
54 S T D QY P Y L R S V C E M A E K G V
AAGACCGTGA CCTCTGCGGC CATGACAAGT GCCCTGCCCA TCATCCAGAA GCTGGAGCCA
74 K T V T S A A M T S A L P I I Q K L E P
CAAATTGCGG TTGCCAATAC CTATGCCTGC AAGGGGCTAG ACAGGATGGA GGAAAGACTG
94 Q I A V A N T Y A C K G L D R M E E R L
CCTATTCTGA ACCAGCCAAC GTCCGAGATT GTTGCCAGTG CCAGAGGTGC CGTAACTGGG
114 P I L N Q P T S E I V A S A R G A V T G
GCGAAGGATG TGGTGACGAC TACCATGGCT GGAGCCAAGG ATTCTGTAGC CAGCACAGTC
134 A K D V V T T T M A G A K D S V A S T V
TCAGGGGTGG TGGATAAGAC CAAAGGAGCA GTGACTGGCA GCGTGGAAAG GACCAAGTCT
154 S G V V D K T K G A V T G S V E R T K S
GTGGTCAATG GCAGCATCAA TACAGTTTTG GGGATGGTGC AGTTCATGAA CAGTGGAGTA
174 V V N G S I N T V L G M V Q F M N S G V
GATAATGCCA TCACCAAGTC GGAGATGCTG GTAGACCAGT ACTTCCCTCT CACTCAGGAG
194 D N A I T K S E M L V D Q Y F P L T Q E
GAGCTGGAGA TGGAAGCAAA AAAGGTGGAA GGATTTGATA TGGTTCAGAA GCCGAGCAAC
214 E L E M E A K K V E G F D M V Q K P S N
TATGAACGGC TGGAGTCCCT GTCTACCAAG CTCTGCTCTC GGGCTTATCA CCAGGCTCTC
234 Y E R L E S L S T K L C S R A Y H Q A L
AGCAGGGTTA AAGAGGCCAA ACAAAAGAGC CAGGAGACCA TTTCTCAGCT CCACTCCACT
254 S R V K E A K Q K S Q E T I S Q L H S T
GTCCACCTGA TTGAATTCGC CAGGAAGAAT ATGCACAGTG CCAACCAGAA AATTCAGGGT
274 V H L I E F A R K N M H S A N Q K I Q G
5-AMP
GCTCAGGATA AGCTCTATGT CTCGTGGGTG GAGTGGAAGA GAAGCATCGG CTACGACGAC
294 A Q D K L Y V S W V E W K R S I G Y D D
5-RT
ACCGATGAGT CCCACTGTGT TGAGCACATC GAGTCACGTA CTCTGGCTAT CGCCCGCAAC
314 T D E S H C V E H I E S R T L A I A R N
CTGACCCAGC AGCTCCAGAC TACATGCCAG ACTGTCCTGG TCAACGCCCA AGGGTTACCA
334 L T Q Q L Q T T C Q T V L V N A Q G L P
CAGAACATTC AAGATCAGGC CAAACACTTG GGGGTGATGG CAGGCGACAT CTACTCCGTA
354 Q N I Q D Q A K H L G V M A G D I Y S V
TTCCGCAATG CTGCCTCCTT TAAGGAAGTG TCCGATGGCG TCCTCACATC TAGCAAGGGG
374 F R N A A S F K E V S D G V L T S S K G
CAGCTGCAGA AAATGAAGGA ATCCTTAGAT GAAGTTATGG ATTACTTTGT TAACAACACG
394 Q L Q K M K E S L D E V M D Y F V N N T
CCTCTCAACT GGCTGGTAGG TCCCTTTTAT CCTCAGTCTA CCGAGGTGAA CAAGGCCAGC
414 P L N W L V G P F Y P Q S T E V N K A S
CTGAAGGTCC AGCAGTCTGA GGTCAAAGCT CAGTAAACCC CTCCTTGTCA CCAGAGCATG
425 L K V Q Q S E V K A Q *
ATGTTGCTGG CCAGATGACC CCTTTTGCTG TATTGAAATT AACTTGGTAG ATGGCTTTAG
CTTAGAAAAG CAGCTTCTTA GAACCAAGGG CCTCATTATG GTCACTCACA GCTCAGTTAT
GGTCTTGCCC CAGCTGGCCC TGGCACAGGA GTTCTCTTAC CTGGCTGGTG AGTGGCCTGT
GTTAGTCTTG TGAGGACCTG GAGGAACCTA AAAGCTCAGA TGCACTTACA GTCTTGTCTG
TGGCCTTTGT ATTGTTATTG GCTGTAAACG TCTGTCTGGA CCGAATAAAG ATTCATTCAC -4
GTGAAAAAAA AAAAAAAAAA //
60
120
180
240
300
360
420
480
540
600
660
720
780
840
900
960
1020
1080
1140
1200
1260
1320
1380
1440
1550
1560
1620
1680
FIG. 2. Nucleotide sequence and deduced amino acid sequence forADRP. The ADRP nucleotide sequence was obtained by direct sequencing
of the cDNA of original clone 154 (11) and cDNAs of 3' and 5' RACE clones. The stop codons prior to the initial codon are boxed and asterisks
represent stop codons within the open reading frame. The poly(A) polymerase recognition site is underlined, and arrows indicate the cDNA
sequence of original clone 154. The 3' RACE primer sequence is underlined, whereas the 5' RACE primers are labeled 5-RT and 5-Amp. The
sequences obtained by RACE protocols were from at least three clones from different PCRs to eliminate possible PCR errors.
Proc. Natl. Acad. Sci. USA 89 (1992) 7859
as one of the amplification primers as described by Frohman
et al. (12). The 5' RACE reaction produced an 41.1-kb weak
and rather broad band after electrophoresis in a 1.0%o agarose
gel, which hybridized strongly with 32P-labeled clone 154
cDNA (data not shown). This DNA fragment was cloned into
the Sma I site in Bluescript SK vector and sequenced. Five
clones containing the 1.1-kb 5' RACE product obtained from
three different PCRs were sequenced to eliminate possible
PCR errors. This yielded an additional 850 bp of sequence
information to the original 154 cDNA sequence. By combin-
ing the sequence oforiginal clone 154cDNA together with the
ones obtained by 3' and 5' RACE reactions, we thereby
obtained a cDNA sequence of 1.7 kb. A major open reading
frame of 1375 bp was found in this 1.7-kb cDNA, which
encodes a protein of 425 amino acids with a molecular mass
of 47 kDa called ADRP. In addition, this open reading frame
was the same as the one found in the original clone 154. As
shown in Fig. 2, the first methionine codon of the open
reading frame (box) is at nucleotide 79; two upstream in-
frame stop codons (underlined) indicate that this represents
the initiation methionine codon. There are two stop codons
at nucleotides 1354 and 1396, respectively, followed by a
stretch of 3' noncoding sequence. A single poly(A) polymer-
ase recognition sequence 5'-AATAAA-3' is located 14 nu-
cleotides upstream of the start of the poly(A) tail.
Both nucleotide sequence and amino acid sequence of the
1.7-kb cDNA were analyzed by a similarity search. No
significant similarity could be found with sequences con-
tained in either the GenBank or the protein data base. In
addition, computer-assisted analysis of functional motifs
such as kinase domains (20), zinc fingers (21), nuclear local-
ization signals (22, 23), signal peptide sequence (24), and
leucine zipper sequences (25, 26) indicated that no such
consensus sequences are present in ADRP.
Expression of ADRP in 1246 Cells Undergoing Differentia-
tion. Polyclonal antibody was raised against ADRP fused to
GST. This antibody was used to follow the expression of
ADRP in 1246 cells undergoing differentiation by Western
blot analysis as described. Cell lysates of the 1246 cells were
collected on day 4, when the cells reach confluency and are
still undifferentiated; on day 5, when the cells start to
differentiate; and on days 6, 8, and 12, when the cells are
undergoing differentiation. As shown in Fig. 3A, a single
band with a molecular mass of 50 kDa was visualized by
Western blotting with anti-ADRP antibody. Expression of
this 50-kDa protein increased as the cells became differenti-
ated. The ADRP could be detected at a very low level on day
4, when 1246 cells reached confluency, it started to increase
on day 5, and it reached a maximum level on day 8. This
increased expression of the 50-kDa protein is in agreement
with the increased expression of clone 154 mRNA observed
in 1246 cells undergoing differentiation (11). The 80-kDa band
observed in all lanes of the Western blot corresponds to a
nonspecific staining as it also appears after incubation with
nonimmune serum. The results ofWestern blot analysis using
a nonimmune rabbit serum as primary antibody did not detect
the 50-kDa protein (data not shown). Moreover, ifanti-ADRP
antiserum was first incubated with excess fusion protein
before being used in the Western analysis, no 50-kDa band
was detected in the differentiated 1246 cells (Fig. 3B).
Loalization of ADRP in 1246 Cells. The distribution of 154
protein in 1246 cells was investigated by immunofluorescence
staining with anti-ADRP antiserum. Experiments were per-
formed on day 8, when the level of ADRP in 1246 cells
reaches a maximum. As shown in Fig. 4, 1246 cells stained
positive with anti-ADRP antiserum. Immunofluorescence
was mainly localized in the cytoplasm in the vicinity of the
plasma membrane. No nuclear localization was observed.
Localization of ADRP was further investigated by immu-
noblotting 1246 subcellular fractions with anti-ADRP anti-
A
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FIG. 3. Identification ofADRP in 1246 cells by Western blotting
analysis. (A) Differentiation of 1246 cells was carried out in defined
medium. Whole-cell lysates were collected at various time points as
indicated. Cell lysates equivalent to 5 x 104 cells for each time point
were used for Western blotting. Samples were electrophoresed on a
10%o polyacrylamide gel according to the method ofLaemmli (18) and
transferred to a filter. The antiserum raised against ADRP-GST
fusion protein was used for immunoblot analysis. (B) Differentiated
1246 cell extracts were subjected to SDS/PAGE as described in A.
After transfer to the filter, the extract was subjected to immunoblot
analysis with anti-154-GST antibody in the absence (lane 1) or
presence (lane 2) of excess 154-GST fusion protein.
body (Fig. 5). The three subcellular fractions were nuclear
fraction (lane c), cytosol fraction (lane d), and particulate
fraction (lane b). Since there was no conventional signal
peptide sequence in the amino acid sequence of clone 154-
encoded protein, indicating that ADRP was not secreted,
conditioned medium of fully differentiated 1246 cells (lane a)
was included as a negative control. The results of Fig. 5
revealed that ADRP was detected predominantly in the
particulate fraction, whereas no detectable amount of this
protein was found in the cytosolic and nuclear fractions.
DISCUSSION
Using the RACE technique (12), we cloned a full-length
cDNA from 1246 adipocytes that encodes a newly identified
protein called ADRP, which is adipose tissue specific in vivo.
The full-length cDNA for ADRP is 1.7 kb and contains an
open reading frame of 1375 bp, which encodes a protein of425
amino acids. The sequence of ADRP cDNA was confirmed
Immunofluorescence
Anti-ADRP
Control
Serum
bright field
Ha
...I, . >
..'
FIG. 4. Localization of ADRP in 1246 cells by immunofluores-
cence. Differentiated 1246 cells were cultivated in chamber slides as
described. The 1246 cells were used on day 8. Cells were fixed and
permeabilized with cold methanol, stained with anti-ADRP antise-
rum or control serum, and then stained with fluorescein isothiocy-
anate-conjugated goat anti-rabbit IgG.
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ob/ob mice when compared to their normal counterparts
(data not shown).
On the basis of these results it is interesting to speculate
that ADRP may play a role in allowing adipocytes to perform
their specialized functions in energy storage and energy
balance. Further studies are necessary to investigate this
possibility and to elucidate the function of ADRP in adipo-
cytes. Moreover, as ADRP is a newly identified protein, its
characterization will provide new insight into the biochem-
istry of adipocytes.
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FIG. 5. Localization of ADRP in 1246 cells by immunoblotting.
Subcellular fractions of 1246 adipocytes were obtained as described.
Twenty micrograms of protein from conditioned medium of 1246
adipocytes (lane a), microsomal fraction (lane b), nuclear fraction
(lane c), or cytosol fraction (lane d) was used for Western blot
analysis. A cell lysate from 1246 adipocytes (lane e) was used as a
positive control.
by sequencing exons of a genomic clone (D. Eisinger and
G.S., unpublished results). Polyclonal antibodies were raised
against the entire ADRP protein expressed as a fusion protein
with GST. By immunoblotting, the polyclonal antibody spe-
cifically recognizes a 50-kDa protein, which correlates with
the calculated molecular mass of -47 kDa based on the
deduced amino acid sequence. We have previously shown
that mRNA corresponding to ADRP is induced in differen-
tiated 1246 cells 1 day after the cells reach confluency (day 5)
(11). In this paper, we have shown by immunoblotting that
the level of the 50-kDa ADRP increases as the cells differ-
entiate, which is in agreement with the increased expression
of its mRNA.
Localization of ADRP protein in 1246 cells by immuno-
blotting indicates that this protein is found not in the cytosol
or nuclear fractions but in the particulate fraction. This
suggests that it is a membrane-associated protein. Sequence
analysis of the protein showed no typical leader sequence or
transmembrane domain, which is generally associated with
either incorporation into membranes or secretion into the
extracellular space. Moreover, analysis of hydropathic char-
acteristics of clone 154 amino acid sequence did not provide
any clue with regard to the location of a structure domain
involved in membrane interaction (data not shown). It is
possible that the membrane association of ADRP protein
could occur during subcellular fractionation of the cells.
However, immunofluorescence staining of fixed 1246 cells
supports the possibility that this protein is preferentially
localized to the inner cell wall. It is not known whetherADRP
is always membrane associated or whether this association is
temporary, as in the case of translocated proteins such as
protein kinase C and phospholipase A2 (27, 28).
Computer-assisted analysis of nucleotide sequence and
deduced amino acid sequence for ADRP revealed no simi-
larity to sequences in DNA and protein data bases. Thus, the
function ofthis protein is at present not known. Northern blot
analysis of RNA extracted from various tissues failed to
detect mRNA corresponding to this protein in nonadipose
tissues, indicating that ADRP mRNA is preferentially ex-
pressed in adipose tissue and may be developmentally reg-
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